Diffuse skeletal pain after administration of alendronate

Area of Science:

• Pharmacology
• Orthopedics
• Rheumatology

Background:

• Osteoporosis results from an imbalance between bone resorption and formation.
• Bisphosphonates are a class of drugs used to inhibit bone resorption.
• Alendronate is a commonly prescribed bisphosphonate for osteoporosis treatment and prevention.

Purpose of the Study:

• To highlight musculoskeletal pain as a potential side effect of bisphosphonate therapy.
• To present a case study of diffuse skeletal pain associated with alendronate administration.
• To emphasize the importance of considering drug-induced pain in osteoporosis patients.

Main Methods:

• Case report of a patient presenting with diffuse skeletal pain.
• Review of patient history following consecutive alendronate administration.
• Clinical assessment of musculoskeletal pain in the context of osteoporosis treatment.

Main Results:

• The patient experienced significant diffuse skeletal pain after three doses of alendronate.
• Gastrointestinal issues are common bisphosphonate side effects, but musculoskeletal pain is also notable.
• The presented case suggests a link between alendronate and severe musculoskeletal pain.

Conclusions:

• Musculoskeletal pain can be a significant side effect of bisphosphonate treatment.
• Healthcare providers should consider bisphosphonate-related pain when evaluating symptoms in osteoporosis patients.
• Differentiating drug-induced pain from underlying disease symptoms is crucial for effective management.